Maternal transmission risk and antibody levels against hepatitis B virus e antigen in pregnant women

International Journal of Infectious Diseases

Volumn 28, Issue , 2014, Pages 41-44

  Lu, Ling Ling ^a,b   Chen, Bing Xiang ^b   Wang, Jiandong ^c   Wang, Dongmei ^a   Ji, Yue ^a   Yi, Hong Gan ^a   Chen, Taoyang ^a   Zhang, Yue ^a   Petersen, Eskild ^d   Li, Qin ^b   Qu, Chunfeng ^a  

^a CANCER HOSPITAL   (China)

^b QIDONG LIVER CANCER INSTITUTE   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Antibodies against HBeAg; Hepatitis B virus; Mother to child transmission

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B VACCINE; HEPATITIS E ANTIGEN; VIRUS ANTIBODY; VIRUS DNA; HEPATITIS B(E) ANTIGEN;

AGED; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; BLOOD LEVEL; CHILD; DELIVERY; FEMALE; HEPATITIS B; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTHER; NEWBORN; NEWBORN PERIOD; PREGNANT WOMAN; SEROLOGY; UMBILICAL CORD BLOOD; VACCINATION; VERTICAL TRANSMISSION; VIRUS LOAD; ADULT; BLOOD; GENETICS; HEPATITIS B VIRUS; IMMUNOLOGY; PREGNANCY; PREGNANCY COMPLICATION; PRESCHOOL CHILD; RISK; TRANSMISSION; VIROLOGY; YOUNG ADULT;

ADULT; CHILD; CHILD, PRESCHOOL; DNA, VIRAL; FEMALE; HEPATITIS B ANTIBODIES; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RISK; YOUNG ADULT;

EID: 84949117617     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2014.07.028     Document Type: Article

References (28)

1. Sun Z., Ming L., Zhu X., Lu J. Prevention and control of hepatitis B in China. J Med Virol 2002, 67:447-450.
2. Zanetti A.R., Van Damme P., Shouval D. The global impact of vaccination against hepatitis B: a historical overview. Vaccine 2008, 26:6266-6273.
3. Chen D.S. Hepatitis B vaccination: the key towards elimination and eradication of hepatitis B. J Hepatol 2009, 50:805-816.
4. Ni Y.H., Huang L.M., Chang M.H., Yen C.J., Lu C.Y., You S.L., et al. Two decades of universal hepatitis B vaccination in Taiwan: impact and implication for future strategies. Gastroenterology 2007, 132:1287-1293.
5. Shao Z.J., Zhang L., Xu J.Q., Xu D.Z., Men K., Zhang J.X., et al. Mother-to-infant transmission of hepatitis B virus: a Chinese experience. J Med Virol 2011, 83:791-795.
6. Yao H.Y., Chen T.Y., Qu C., Lu L.L. Efficacy and some issues of neonatal hepatitis B vaccination against chronic hepatitis B virus infection in mainland of China. Chin Sci Bull 2012, 57:7.
7. Wen W.H., Chang M.H., Zhao L.L., Ni Y.H., Hsu H.Y., Wu J.F., et al. Mother-to-infant transmission of hepatitis B virus infection: significance of maternal viral load and strategies for intervention. J Hepatol 2013, 59:24-30.
8. Lee A.K., Ip H.M., Wong V.C. Mechanisms of maternal-fetal transmission of hepatitis B virus. J Infect Dis 1978, 138:668-671.
9. Osiowy C. Detection of HBsAg mutants. J Med Virol 2006, 78(Suppl 1):S48-S51.
10. Ganem D., Prince A.M. Hepatitis B virus infection-natural history and clinical consequences. N Engl J Med 2004, 350:1118-1129.
11. Dwivedi M., Misra S.P., Misra V., Pandey A., Pant S., Singh R., et al. Seroprevalence of hepatitis B infection during pregnancy and risk of perinatal transmission. Indian J Gastroenterol 2011, 30:66-71.
12. Guo Z., Shi X.H., Feng Y.L., Wang B., Feng L.P., Wang S.P., et al. Risk factors of HBV intrauterine transmission among HBsAg-positive pregnant women. J Viral Hepat 2013, 20:317-321.
13. Hsu Y.S., Chien R.N., Yeh C.T., Sheen I.S., Chiou H.Y., Chu C.M., et al. Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B. Hepatology 2002, 35:1522-1527.
14. Lu J. Matched prospective study of primary hepatocellular carcinoma in chronic carriers of HBsAg. Chinese Journal of Oncology 1983, 5:406-408.
15. Sun Z., Chen T., Thorgeirsson S.S., Zhan Q., Chen J., Park J.H., et al. Dramatic reduction of liver cancer incidence in young adults: 28 year follow-up of etiological interventions in an endemic area of China. Carcinogenesis 2013, 34:1800-1805.
16. Xu L., Wei Y., Chen T., Lu J., Zhu C.L., Ni Z., et al. Occult HBV infection in anti-HBs-positive young adults after neonatal HB vaccination. Vaccine 2010, 28:5986-5992.
17. Kwok S., Higuchi R. Avoiding false positives with PCR. Nature 1989, 339:237-238.
18. Chen J., Yin J., Tan X., Zhang H., Zhang H., Chen B., et al. Improved multiplex-PCR to identify hepatitis B virus genotypes A-F and subgenotypes B1, B2, C1 and C2. J Clin Virol 2007, 38:238-243.
19. Norder H., Courouce A.M., Coursaget P., Echevarria J.M., Lee S.D., Mushahwar I.K., et al. Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology 2004, 47:289-309.
20. Huovila A.P., Eder A.M., Fuller S.D. Hepatitis B surface antigen assembles in a post-ER, pre-Golgi compartment. J Cell Biol 1992, 118:1305-1320.
21. Bruss V. Envelopment of the hepatitis B virus nucleocapsid. Virus Res 2004, 106:199-209.
22. Tabuchi A., Tanaka J., Katayama K., Mizui M., Matsukura H., Yugi H., et al. Titration of hepatitis B virus infectivity in the sera of pre-acute and late acute phases of HBV infection: transmission experiments to chimeric mice with human liver repopulated hepatocytes. J Med Virol 2008, 80:2064-2068.
23. Xu W.M., Cui Y.T., Wang L., Yang H., Liang Z.Q., Li X.M., et al. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study. J Viral Hepat 2009, 16:94-103.
24. Han G.R., Cao M.K., Zhao W., Jiang H.X., Wang C.M., Bai S.F., et al. A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection. J Hepatol 2011, 55:1215-1221.
25. Waters J.A., O'Rourke S.M., Richardson S.C., Papaevangelou G., Thomas H.C. Qualitative analysis of the humoral immune response to the 'a' determinant of HBs antigen after inoculation with plasma-derived or recombinant vaccine. J Med Virol 1987, 21:155-160.
26. Carman W.F., Zanetti A.R., Karayiannis P., Waters J., Manzillo G., Tanzi E., et al. Vaccine-induced escape mutant of hepatitis B virus. Lancet 1990, 336:325-329.
27. Chen H.B., Fang D.X., Li F.Q., Jing H.Y., Tan W.G., Li S.Q. A novel hepatitis B virus mutant with A-to-G at nt551 in the surface antigen gene. World J Gastroenterol 2003, 9:304-308.
28. Yin J., Zhang H., He Y., Xie J., Liu S., Chang W., et al. Distribution and hepatocellular carcinoma-related viral properties of hepatitis B virus genotypes in Mainland China: a community-based study. Cancer Epidemiol Biomarkers Prev 2010, 19:777-786.